Cargando…
The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660629/ https://www.ncbi.nlm.nih.gov/pubmed/31413639 http://dx.doi.org/10.2147/CLEP.S206017 |
_version_ | 1783439337256386560 |
---|---|
author | Ruiz-Ruiz, Francisco Menéndez-Orenga, Miguel Medrano, Francisco J Calderón, Enrique J Lora-Pablos, David Navarro-Puerto, Maria Asunción Rodríguez-Torres, Patricia Gómez de la Cámara, Agustín |
author_facet | Ruiz-Ruiz, Francisco Menéndez-Orenga, Miguel Medrano, Francisco J Calderón, Enrique J Lora-Pablos, David Navarro-Puerto, Maria Asunción Rodríguez-Torres, Patricia Gómez de la Cámara, Agustín |
author_sort | Ruiz-Ruiz, Francisco |
collection | PubMed |
description | PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompensated HF: PREDICE and AHEAD. The secondary aim was to evaluate in our setting the changes in the clinical pattern of HF in the last decade in patients hospitalized for a first episode of the disease. PATIENTS AND METHODS: A prospective multicenter cohort study, which included 180 patients hospitalized with “de novo” HF was conducted to validate the PREDICE score. Calibration and discrimination measurements were calculated for the PREDICE model and the PREDICE score (using the validation cohort of the PREDICE) and the AHEAD score (using both the development and the validation cohort of the PREDICE). RESULTS: For the PREDICE models, the area under the curve (AUC) was 0.68 (95% confidence interval [CI]: 0.57–0.79) and the calibration slope 0.65 (95% CI: 0.21–1.20). For the PREDICE score AUC was 0.59 (95% CI: 0.47–0.71) and slope 0.42 (95% CI: −0.20–1.17). For the AHEAD score the AUC was 0.68 (95% CI: 0.62–0.73) and slope 1.38 (95% CI: 0.62–0.73) when used the development cohort of PREDICE and the AUC was 0.58 (95% CI: 0.49–0.67), and slope 0.68 (95% CI: −0.06 to 1.47) when used its validation cohort. CONCLUSION: The present study shows that the two risk scores available for patients with primo-hospitalization for decompensated HF (PREDICE and AHEAD) are not currently valid for predicting mortality at one-year. In our setting the clinical spectrum of hospitalized patients with new-onset HF has been modified over time. The study underscores the need to validate the prognostic models before clinical implementation. |
format | Online Article Text |
id | pubmed-6660629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66606292019-08-14 The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD Ruiz-Ruiz, Francisco Menéndez-Orenga, Miguel Medrano, Francisco J Calderón, Enrique J Lora-Pablos, David Navarro-Puerto, Maria Asunción Rodríguez-Torres, Patricia Gómez de la Cámara, Agustín Clin Epidemiol Original Research PURPOSE: Heart failure (HF) is a chronic, frequent and disabling condition but with a modifiable course and a large potential for improving. The aim of this study was to validate the two available clinical prediction rules for mortality at one year in patients with primo-hospitalization for decompensated HF: PREDICE and AHEAD. The secondary aim was to evaluate in our setting the changes in the clinical pattern of HF in the last decade in patients hospitalized for a first episode of the disease. PATIENTS AND METHODS: A prospective multicenter cohort study, which included 180 patients hospitalized with “de novo” HF was conducted to validate the PREDICE score. Calibration and discrimination measurements were calculated for the PREDICE model and the PREDICE score (using the validation cohort of the PREDICE) and the AHEAD score (using both the development and the validation cohort of the PREDICE). RESULTS: For the PREDICE models, the area under the curve (AUC) was 0.68 (95% confidence interval [CI]: 0.57–0.79) and the calibration slope 0.65 (95% CI: 0.21–1.20). For the PREDICE score AUC was 0.59 (95% CI: 0.47–0.71) and slope 0.42 (95% CI: −0.20–1.17). For the AHEAD score the AUC was 0.68 (95% CI: 0.62–0.73) and slope 1.38 (95% CI: 0.62–0.73) when used the development cohort of PREDICE and the AUC was 0.58 (95% CI: 0.49–0.67), and slope 0.68 (95% CI: −0.06 to 1.47) when used its validation cohort. CONCLUSION: The present study shows that the two risk scores available for patients with primo-hospitalization for decompensated HF (PREDICE and AHEAD) are not currently valid for predicting mortality at one-year. In our setting the clinical spectrum of hospitalized patients with new-onset HF has been modified over time. The study underscores the need to validate the prognostic models before clinical implementation. Dove 2019-07-22 /pmc/articles/PMC6660629/ /pubmed/31413639 http://dx.doi.org/10.2147/CLEP.S206017 Text en © 2019 Ruiz-Ruiz et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ruiz-Ruiz, Francisco Menéndez-Orenga, Miguel Medrano, Francisco J Calderón, Enrique J Lora-Pablos, David Navarro-Puerto, Maria Asunción Rodríguez-Torres, Patricia Gómez de la Cámara, Agustín The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title | The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title_full | The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title_fullStr | The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title_full_unstemmed | The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title_short | The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD |
title_sort | prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: predice and ahead |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660629/ https://www.ncbi.nlm.nih.gov/pubmed/31413639 http://dx.doi.org/10.2147/CLEP.S206017 |
work_keys_str_mv | AT ruizruizfrancisco theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT menendezorengamiguel theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT medranofranciscoj theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT calderonenriquej theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT lorapablosdavid theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT navarropuertomariaasuncion theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT rodrigueztorrespatricia theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT gomezdelacamaraagustin theprognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT ruizruizfrancisco prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT menendezorengamiguel prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT medranofranciscoj prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT calderonenriquej prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT lorapablosdavid prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT navarropuertomariaasuncion prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT rodrigueztorrespatricia prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead AT gomezdelacamaraagustin prognosisofpatientshospitalizedwithafirstepisodeofheartfailurevalidationoftwoscoresprediceandahead |